# Michael Schultze

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-schultze/

## Facts

| Field | Value |
| --- | --- |
| Citations | 78 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 6 |
| i10-index | 2 |
| Last Known Institution | Berlin Center for Epidemiology and Health Research |
| OpenAlex ID | https://openalex.org/A5053685401 |
| ORCID iD | 0009-0002-1494-5446 |
| Works | 22 |

## Researcher papers

- [Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany](https://scholariq.org/papers/population-estimates-of-obstructive-and-non-obstructive-hypertrophic/)
- [Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study](https://scholariq.org/papers/evaluation-of-adherence-and-persistence-to-triple-therapy-in-patients-with-copd/)
- [Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis](https://scholariq.org/papers/real-world-burden-of-immunosuppressant-treated-lupus-nephritis-a-german-claims/)
- [Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany](https://scholariq.org/papers/clinical-and-economic-burden-of-organ-damage-among-patients-with-systemic-lupus/)
- [Real-world treatment patterns and survival outcomes in patients with locally advanced squamous cell carcinoma of the head and neck in Germany using claims data](https://scholariq.org/papers/real-world-treatment-patterns-and-survival-outcomes-in-patients-with-locally/)
- [Epidemiology of Wilson disease in Germany – real-world insights from a claims data study](https://scholariq.org/papers/epidemiology-of-wilson-disease-in-germany-real-world-insights-from-a-claims-data/)
- [Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort Study](https://scholariq.org/papers/treatment-patterns-and-adherence-to-guidelines-for-uncomplicated-urinary-tract/)
- [Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis](https://scholariq.org/papers/treatment-and-associated-outcomes-of-type-2-diabetes-mellitus-patients-with-a/)
- [MO505: Prevalence of Lupus Nephritis Among Patients With Systemic Lupus Erythematosus In Germany](https://scholariq.org/papers/mo505-prevalence-of-lupus-nephritis-among-patients-with-systemic-lupus/)
- [Real-world psoriasis treatment patterns and disease burden in Germany, with a focus on biologics and apremilast: data from a German statutory health insurance database](https://scholariq.org/papers/real-world-psoriasis-treatment-patterns-and-disease-burden-in-germany-with-a/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Researcher university

- [Berlin Center for Epidemiology and Health Research](https://scholariq.org/institutions/berlin-center-for-epidemiology-and-health-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.